These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 12748904

  • 1. [Use of low-molecular-weight heparins in patients with prosthetic heart valves].
    Hering D, Horstkotte D.
    Dtsch Med Wochenschr; 2003 May 16; 128(20):1129-33. PubMed ID: 12748904
    [No Abstract] [Full Text] [Related]

  • 2. Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves.
    James AH, Brancazio LR, Gehrig TR, Wang A, Ortel TL.
    J Matern Fetal Neonatal Med; 2006 Sep 16; 19(9):543-9. PubMed ID: 16966122
    [Abstract] [Full Text] [Related]

  • 3. [Recurrent thrombosis of a mitral mechanical heart valve prosthesis during puerperium--a case report].
    Lisowska A, Prokop J, Hirnle T, Juszczyk G, Skibińska E, Musiał WJ, Klonowska-Dziatkiewicz E.
    Kardiol Pol; 2004 Jul 16; 61(7):49-51; discussion 52. PubMed ID: 15338018
    [Abstract] [Full Text] [Related]

  • 4. eComment: Are low molecular weight heparin effective in mechanical valve prosthesis anticoagulation during pregnancy?
    Carrascal Y.
    Interact Cardiovasc Thorac Surg; 2010 Jan 16; 10(1):118-9. PubMed ID: 20019046
    [No Abstract] [Full Text] [Related]

  • 5. Low-molecular-weight heparin in pregnant women with prosthetic heart valves.
    Descarries LM, Leduc L, Khairy P, Mercier LA.
    J Heart Valve Dis; 2006 Sep 16; 15(5):679-85. PubMed ID: 17044374
    [Abstract] [Full Text] [Related]

  • 6. Anticoagulant therapy in pregnant women with mechanical heart valves.
    Leyh RT, Fischer S, Ruhparwar A, Haverich A.
    Arch Gynecol Obstet; 2003 Apr 16; 268(1):1-4. PubMed ID: 12673466
    [Abstract] [Full Text] [Related]

  • 7. Anticoagulation therapy in patients with prosthetic heart valves.
    Douketis JD.
    Clin Adv Hematol Oncol; 2007 Jun 16; 5(6):436-8. PubMed ID: 17679917
    [No Abstract] [Full Text] [Related]

  • 8. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: case report and a review of options for anticoagulation.
    Mahesh B, Evans S, Bryan AJ.
    J Heart Valve Dis; 2002 Sep 16; 11(5):745-50. PubMed ID: 12358414
    [Abstract] [Full Text] [Related]

  • 9. Can we use a low molecular weight heparin after mechanical prosthetic heart valve surgery?
    Meurin P, Tabet JY.
    Heart; 2008 Feb 16; 94(2):131-2. PubMed ID: 18195116
    [No Abstract] [Full Text] [Related]

  • 10. Low molecular weight heparin in management of intracerebellar hemorrhage in patient with mitral and aortic prosthetic valves.
    Jain AK, Lal V, Sharma YP, Grover A.
    Neurol India; 2002 Sep 16; 50(3):373-4. PubMed ID: 12391476
    [No Abstract] [Full Text] [Related]

  • 11. The use of low-molecular-weight heparins in pregnancy--how safe are they?
    Deruelle P, Coulon C.
    Curr Opin Obstet Gynecol; 2007 Dec 16; 19(6):573-7. PubMed ID: 18007136
    [Abstract] [Full Text] [Related]

  • 12. 'Heparin rebound' means the opposite in cardiac surgery (bleeding) and in cardiology (thrombosis).
    Koracevic G.
    Blood Coagul Fibrinolysis; 2010 Mar 16; 21(2):198-9. PubMed ID: 20118712
    [No Abstract] [Full Text] [Related]

  • 13. The obstetrical patient with a prosthetic heart valve.
    Danik S, Fuster V.
    Obstet Gynecol Clin North Am; 2006 Sep 16; 33(3):481-91. PubMed ID: 16962923
    [Abstract] [Full Text] [Related]

  • 14. Thrombogenesis and anticoagulation in heart valve disease: towards a rational approach.
    Butchart EG.
    J Heart Valve Dis; 1993 Jan 16; 2(1):1-6. PubMed ID: 8269101
    [No Abstract] [Full Text] [Related]

  • 15. Acute thrombosis of a prosthetic mitral valve: a lesson in anticoagulation.
    Sharma R, Ooi A, Jokhi P, Tsang GM, Simpson IA.
    J Am Soc Echocardiogr; 2007 Aug 16; 20(8):1010.e7-9. PubMed ID: 17555942
    [Abstract] [Full Text] [Related]

  • 16. Comparison of fondaparinux, low molecular-weight heparin and unfractionated heparin in preventing thrombus formation on mechanical heart valves: results of an in-vitro study.
    Schlitt A, Hamilton K, Maegdefessel L, Dahm M, Theis C, Eichler M, Brockmann O, Steinseifer U, Hauroeder B, Hitzler WE, Rupprecht HJ.
    J Heart Valve Dis; 2006 Nov 16; 15(6):809-14. PubMed ID: 17152789
    [Abstract] [Full Text] [Related]

  • 17. Anti-Xa activity with low-molecular-weight heparin, enoxaparin, during pregnancy in women with mechanical heart valves.
    Izaguirre R, De La Peña A, Ramírez A, Cortina E, Huerta M, Salazar E.
    Proc West Pharmacol Soc; 2002 Nov 16; 45():127-8. PubMed ID: 12434554
    [No Abstract] [Full Text] [Related]

  • 18. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y, Siu SC, Warshafsky C, Maxwell C, McLeod A, Colman JM, Sermer M, Silversides CK.
    Am J Cardiol; 2009 Nov 01; 104(9):1259-63. PubMed ID: 19840573
    [Abstract] [Full Text] [Related]

  • 19. The use of low molecular weight heparin during pregnancy in patients with mechanical heart valves carries potential risk for valve thrombosis: a report of three cases.
    Senol U, Ulus T, Birdane A, Cavuşoğlu Y.
    Turk Kardiyol Dern Ars; 2014 Apr 01; 42(3):294-8. PubMed ID: 24769825
    [Abstract] [Full Text] [Related]

  • 20. Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement.
    Meurin P, Tabet JY, Weber H, Renaud N, Ben Driss A.
    Circulation; 2006 Jan 31; 113(4):564-9. PubMed ID: 16449734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.